Article Details - Overview

View all Online CME

Continuing Education Information

Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Case Studies in Oncology Vol. 9, No. 2

Release Date: November 18, 2008
Expiration Date: November 18, 2009

Publication Overview

Author

Weijing Sun, MD

Overview and Purpose

Pancreatic cancer remains a clinical management challenge, with a 1-year overall survival rate of < 20% for patients diagnosed with advanced disease receiving standard antimetabolite chemotherapy. The addition of targeted agents, including inhibitors of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR), in combination with standard antimetabolite therapy has yielded modest benefits in some patients; however, there is an urgent need to develop improved treatment regimens for patients with pancreatic cancer through clinical trials research.

The purpose of this activity is to inform medical oncologists of recent data on targeted agents for patients with advanced pancreatic cancer and to outline clinical trial options for these patients.

Target Audience

This activity is intended for medical oncologists involved in the care of patients with pancreatic cancer. No specific skills or knowledge other than a basic training in oncology is required for successful participation in this activity.

Learning Objectives

Upon completion of this educational activity, you should be able to:

  • Review the clinical benefit of targeting EGFR in advanced pancreatic cancer
  • Discuss the safety of combining gemcitabine with agents targeting angiogenesis and EGFR in advanced pancreatic cancer
  • Discuss the role of combining EGFR and VEGF inhibition in the management of pancreatic cancer

Instructions for Participation

  1. Read the following information before entering the educational activity.
  2. Complete the Pretest.
  3. Study the educational activity.
  4. Complete the CME test.
  5. Answer the evaluation questions.
  6. After successful completion of the CME test and evaluation, you will receive your certificate of credit online.

CME credit will be granted for only 1 form of participation, either online or via the printed publication.

View the Activity
You will be asked to login
or create an account.